ICE consists of three directorates to accomplish the agency’s mission, including Homeland Security Investigations (HSI), Enforcement and Removal Operations (ERO) and Management and Administration (M&A).

ICE executes its mission through the enforcement of more than 400 federal statutes, and focuses on smart immigration enforcement, preventing terrorism and combating the illegal movement of people and trade. (read more)

This sentence was announced by U.S. Attorney Kenneth Magidson, Assistant Attorney General Leslie R. Caldwell of the Justice Department's Criminal Division and Special Agent in Charge Brian Moskowitz, of U.S. Immigration and Customs Enforcement's (ICE) Homeland Security Investigations (HSI) Houston.

This investigation was conducted by the following agencies: HSI, the Food and Drug Administration's (FDA) Office of Criminal Investigations, the Department of State's Diplomatic Security Service, and police departments in Houston and Chicago.

"This conviction and prison sentence are the culmination of a multi-agency effort to prevent counterfeit pharmaceuticals from being smuggled and distributed into the United States," said Moskowitz. "Intellectual property-related crimes such as this remind us of the potential public-safety hazards posed by IP thieves who care more about profits than people."

Fayez Al-Jabri, 45, of Chicago, Illinois, was sentenced by U.S. District Judge Nancy F. Atlas. In addition to his prison term, Al-Jabri will serve three years of supervised release and must pay $15,066.92 in restitution. On March 21, Al-Jabri pleaded guilty to one count of conspiracy to traffic in counterfeit goods, to introduce misbranded prescription drugs into interstate commerce, and to import such goods contrary to U.S. law; he also pleaded guilty to one count of trafficking in counterfeit goods; and one count of introducing counterfeit drugs into interstate commerce in violation of the Food, Drug and Cosmetic Act.

Al-Jabri was indicted Aug. 22, 2012, along with one other individual, Jamal Khattab, 49, of Katy, Texas, for their respective roles in the conspiracy. Khattab pleaded guilty to the same charges Dec. 3, 2013; his sentencing is scheduled for Aug. 14.

According to court documents, Al-Jabri conspired to traffic in more than 26,000 counterfeit Viagra tablets over the course of the conspiracy, including shipping thousands of counterfeit Viagra tablets from Chicago to an undercover HSI special agent in Houston from July 2011 through October 2012. HSI submitted all the tablets seized during the investigation for analysis to both the FDA and to Pfizer, Viagra's manufacturer. Both the FDA and Pfizer identified the tablets as counterfeit and misbranded Viagra.

This case is being prosecuted by Assistant U.S. Attorneys Kebharu Smith and Jennifer Lowery, Southern District of Texas, and Assistant Deputy Chief for Litigation John H. Zacharia of the Criminal Division's Computer Crime and Intellectual Property Section.

Share

Last Reviewed/Updated: 09/23/2014

Related Information

Media Inquiries

For media inquiries about ICE activities, operations, or policies, contact the ICE Office of Public Affairs at (202) 732-4242.